|
1. |
Early risk of cardiovascular events after commencing hormone replacement therapy |
|
Current Opinion in Lipidology,
Volume 12,
Issue 4,
2001,
Page 371-375
Jacques Rossouw,
Preview
|
PDF (71KB)
|
|
ISSN:0957-9672
出版商:OVID
年代:2001
数据来源: OVID
|
2. |
Cholesteryl ester transfer protein, high density lipoprotein and arterial disease |
|
Current Opinion in Lipidology,
Volume 12,
Issue 4,
2001,
Page 377-382
Philip Barter,
Kerry-Anne Rye,
Preview
|
PDF (73KB)
|
|
摘要:
The reported relationships between cholesteryl ester transfer protein, high density lipoproteins and arterial disease are confusing and conflicting. Several papers published during the review period add substantially to the evidence base regarding the atherogenicity (or anti-atherogenicity) of cholesteryl ester transfer protein, although none clearly resolves the continuing conflict. These new papers are presented against the backdrop of the previous state of knowledge.
ISSN:0957-9672
出版商:OVID
年代:2001
数据来源: OVID
|
3. |
Endothelial function and coronary artery disease |
|
Current Opinion in Lipidology,
Volume 12,
Issue 4,
2001,
Page 383-389
Scott Kinlay,
Peter Libby,
Peter Ganz,
Preview
|
PDF (101KB)
|
|
摘要:
The endothelium produces a number of vasodilator and vasoconstrictor substances that not only regulate vasomotor tone, but also the recruitment and activity of inflammatory cells and the propensity towards thrombosis. Endothelial vasomotor function is a convenient way to assess these other functions, and is related to the long-term risk of cardiovascular disease. Lipids (particularly low density lipoprotein cholesterol) and oxidant stress play a major role in impairing these functions, by reducing the bioavailability of nitric oxide and activating pro-inflammatory signalling pathways such as nuclear factor kappa B. Biomechanical forces on the endothelium, including low shear stress from disturbed blood flow, also activate the endothelium increasing vasomotor dysfunction and promoting inflammation by upregulating pro-atherogenic genes. In contrast, normal laminar shear stress promotes the expression of genes that may protect against atherosclerosis. The sub-cellular structure of endothelial cells includes caveolae that play an integral part in regulating the activity of endothelial nitric oxide synthase. Low density lipoprotein cholesterol and oxidant stress impair caveolae structure and function and adversely affect endothelial function. Lipid-independent pathways of endothelial cell activation are increasingly recognized, and may provide new therapeutic targets. Endothelial vasoconstrictors, such as endothelin, antagonize endothelium-derived vasodilators and contribute to endothelial dysfunction. Some but not all studies have linked certain genetic polymorphisms of the nitric oxide synthase enzyme to vascular disease and impaired endothelial function. Such genetic heterogeneity may nonetheless offer new insights into the variability of endothelial function.
ISSN:0957-9672
出版商:OVID
年代:2001
数据来源: OVID
|
4. |
Pleiotropic effects of statins: do they matter? |
|
Current Opinion in Lipidology,
Volume 12,
Issue 4,
2001,
Page 391-394
Antonio Gotto,
John Farmer,
Preview
|
PDF (61KB)
|
|
摘要:
Treatment with the 3-hydroxy-3-methylglutaryl coenyzme A reductase inhibitors (or statins) reduces the risk for cardiovascular events across a broad spectrum of patient profiles, as evidenced by both primary prevention and secondary prevention trials. Improved survival by way of reduced deaths from coronary heart disease was also reported with these agents, which are primarily indicated for substantial reduction in LDL-cholesterol levels. However, the statins are extremely complex drugs and exhibit a wide variety of vascular effects that may or may not be dependent on their lipid-modifying properties. These so-called pleiotropic effects include alterations of endothelial function, inflammation, coagulation, and plaque stability. The relative contribution of the nonlipid effects of statin therapy to the well-documented clinical benefits is currently under intense investigation.
ISSN:0957-9672
出版商:OVID
年代:2001
数据来源: OVID
|
5. |
Dietary carbohydrates, physical inactivity, obesity, and the ‘metabolic syndrome’ as predictors of coronary heart disease |
|
Current Opinion in Lipidology,
Volume 12,
Issue 4,
2001,
Page 395-404
Simin Liu,
JoAnn Manson,
Preview
|
PDF (124KB)
|
|
摘要:
Several decades of epidemiological and clinical research have identified physical inactivity, excessive calorie consumption, and excess weight as common risk factors for both type 2 diabetes mellitus and coronary heart disease. This trio forms the environmental substrate for a now well-recognized metabolic phenotype called the insulin resistance syndrome. Recent data suggest that a high intake of rapidly absorbed carbohydrates, which is characterized by a high glycemic load (a measure of carbohydrate quality and quantity), may increase the risk of coronary heart disease by aggravating glucose intolerance and dyslipidemia. These data also suggest that individuals who are obese and insulin resistant are particularly prone to the adverse effects of a high dietary glycemic load. In addition, data continue to accumulate suggesting the important beneficial effects of physical activity, even at moderate levels, and weight reduction on improving insulin sensitivity and reducing the risk of coronary heart disease. Future metabolic studies should continue to quantify the physiological impact of different foods on serum glucose and insulin, and such information should routinely be incorporated into large-scale and long-term prospective studies, in which the possible interaction effects between diet and other metabolic determinants such as physical activity and obesity can be examined. Until more definitive data are available, replacing refined grain products and potatoes with minimally processed plant-based foods such as whole grains, fruits, and vegetables, and reducing the intake of high glycemic load beverages may offer a simple strategy for reducing the incidence of coronary heart disease.
ISSN:0957-9672
出版商:OVID
年代:2001
数据来源: OVID
|
6. |
Genetic polymorphisms, lipoproteins and coronary artery disease risk |
|
Current Opinion in Lipidology,
Volume 12,
Issue 4,
2001,
Page 405-409
Philippa Talmud,
Steve Humphries,
Preview
|
PDF (90KB)
|
|
摘要:
Association studies between gene variants (polymorphisms) and measured intermediate phenotypes, such as lipid/lipoprotein levels, or disease endpoints such as coronary artery disease, are commonplace in the literature. But have we learnt anything from the shortcomings in study design and analytical strategies that have resulted in much controversy in this field over the last few years? This review highlights some of these problems. Using the lipoprotein lipase gene as an example, we evaluate new approaches to identifying polymorphisms that will stand up to linkage disequilibrium/association studies with complex disorders in this post Human Genome Project age, and emphasize the importance of gene-environment interaction in assessing the impact of gene variants.
ISSN:0957-9672
出版商:OVID
年代:2001
数据来源: OVID
|
7. |
Oxidants and antioxidants in atherosclerosis |
|
Current Opinion in Lipidology,
Volume 12,
Issue 4,
2001,
Page 411-418
Ryuichi Mashima,
Paul Witting,
Roland Stocker,
Preview
|
PDF (102KB)
|
|
摘要:
The oxidative theory suggests that LDL oxidation contributes to atherogenesis, implying that attenuation of this process by antioxidants should decrease atherosclerosis. However, a causative link between LDL oxidation and atherogenesis is not firmly established. It requires the identification of the oxidants that are responsible for the initiation of LDL oxidation, and an understanding of the modified moieties that are responsible for the proatherogenic activities of oxidized LDL. The present review summarizes recent data on potential biological oxidants for LDL in the vessel wall, and discusses the antiatherogenic role(s) of selected antioxidants.
ISSN:0957-9672
出版商:OVID
年代:2001
数据来源: OVID
|
8. |
Roles of lectin-like oxidized LDL receptor-1 and its soluble forms in atherogenesis |
|
Current Opinion in Lipidology,
Volume 12,
Issue 4,
2001,
Page 419-423
Noriaki Kume,
Toru Kita,
Preview
|
PDF (76KB)
|
|
摘要:
Lectin-like oxidized LDL receptor (LOX)-1 is a type II membrane protein that belongs to the C-type lectin family of molecules, which can act as a cell-surface endocytosis receptor for atherogenic oxidized LDL. LOX-1 can support binding, internalization and proteolytic degradation of oxidized LDL, but not of significant amounts of acetylated LDL, which is a well-known high-affinity ligand for class A scavenger receptors and scavenger receptor expressed by endothelial cells (SR-EC). LOX-1 is initially synthesized as a 40-kDa precursor protein with N-linked high mannose-type carbohydrate, which is further glycosylated and processed into a 50-kDa mature form. LOX-1 expression is not constitutive, but can be induced by proinflammatory stimuli, such as tumour necrosis factor-α, transforming growth factor-β and bacterial endotoxin, as well as angiotensin II, oxidized LDL itself and fluid shear stress. In addition, LOX-1 expression is detectable in cultured macrophages and activated vascular smooth muscle cells.In vivo, endothelial cells that cover early atherosclerotic lesions, and intimal macrophages and smooth muscle cells in advanced atherosclerotic plaques can express LOX-1. Cell-surface LOX-1 can be cleaved through some protease activities that are associated with the plasma membrane, and released into the culture media. Purification of soluble LOX-1 and the N-terminal amino-acid sequencing identified the two cleavage sites (Arg86-Ser87 and Lys89-Ser90), both of which are located in the membrane proximal extracellular domain of LOX-1. Measurement of soluble LOX-1in vivomay provide a novel diagnostic tool for the evaluation and prediction of atherosclerosis and vascular disease.
ISSN:0957-9672
出版商:OVID
年代:2001
数据来源: OVID
|
9. |
Diabetes and other coronary heart disease risk equivalents |
|
Current Opinion in Lipidology,
Volume 12,
Issue 4,
2001,
Page 425-431
Richard James,
Preview
|
PDF (82KB)
|
|
摘要:
The close association between diabetes and cardiovascular disease suggests that current predictions of a massive increase in the prevalence of type 2 diabetes foreshadow an equally daunting rise in the incidence of vascular disease. The limited cardiovascular benefits obtained by glucose-lowering treatments, although perhaps not surprising, indicate that other cardiovascular risk factors must be given serious consideration as therapeutic targets. The impressive reductions in the number of vascular events observed in diabetic patients, albeit in small patient populations, participating in various drug trials amply justify such an approach. A necessary prerequisite, however, is a clear understanding of the clinical importance of individual risk factors to the occurrence of vascular disease in type 2 diabetic patients. This would appear essential for defining treatment strategies in the face of a bewildering array of potential therapeutic targets. The present review considers recent studies that have assessed the predictive value of risk factors against a diabetic background.
ISSN:0957-9672
出版商:OVID
年代:2001
数据来源: OVID
|
10. |
Soy protein isoflavones, lipids and arterial disease |
|
Current Opinion in Lipidology,
Volume 12,
Issue 4,
2001,
Page 433-437
Mara Vitolins,
Mary Anthony,
Gregory Burke,
Preview
|
PDF (68KB)
|
|
摘要:
There is convincing evidence that soybean products have beneficial effects on cardiovascular disease risk factors. Interest in understanding which components of the soybean are responsible for the potential benefits on cardiovascular disease risk factors and the magnitude of their effect continues. This review focuses on the scientific literature published during 1999-2001, evaluating the effects of soy protein isolate, soy foods, and purified isoflavones on plasma lipid concentrations and other cardiovascular disease outcomes.
ISSN:0957-9672
出版商:OVID
年代:2001
数据来源: OVID
|
|